Category Archives: Mesenchymal Stem Cells

27-12-2011 00:09 Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, travel arrangements and language assistance. If you want to know more about our services, please browse the web:htttp://www.medicaltourism.hk/ or mail to us: giels-x@medicaltourism.hk firstcare-china@hotmail.com Tamara sat for an interview in China after receiving treatment to the south of the city Original post: China medical tourism--Spinal Injury--Stem Cell - Video … Continue reading →

CIRM has funded a $9 million disease team to develop a more effective and safer bone marrow transplant to treat sickle cell disease. The team is led by Dr. Donald Kohn, director of the Human Gene Medicine Program at UCLA. Continued here: Stem Cell Therapy for Sickle Cell Anemia - Video … Continue reading →

NBC Interviews Dr. Go here to see the original: GeneCell Dental Pulp Stem Cells NBC6 Interview with Dr. Todd Flower, PhD - Video … Continue reading →

As with umbilical cord blood banking, GeneCell International is at the forefront of the research and the technology developed to process and store stem cells found within the dental pulp. Although most people are familiar with banking cord , few people are aware of the advantages of harvesting stem cells from the dental pulp: •Dental pulp can be obtained unobtrusively as children or adults lose teeth •The stem cells found in dental pulp are non-controversial adult stem cells (mesenchymal stem cells) •Dental pulp stem cells are excellent candidates for regenerative medicine and tissue engineering applications GeneCell International is committed to excellence in cell processing and cryogenically storing your dental pulp stem cells. Using state-of-the-art equipment and highly qualified, laboratory personnel, we ensure the highest quality standard is upheld thus providing the best possible service for our clients. More here: GeneCell International Dental Pulp Stem Cell's Banking Services - Video … Continue reading →

Stem Cell Treatment email update from Holly Catalano's mother, Carolyn to the Stem Cell Institute's CEO, Pablo de la Hoya. Holly was treated for periventricular leukomalacia, a disorder that is similar to cerebral palsy See the rest here: Stem Cell Therapy - Cerebral Palsy Treatment || Holly Catalano Update - Video … Continue reading →

UCL Lunch Hour Lecture: Prometheus and I: building new body parts from stem cells Professor Martin Birchall (UCL Ear Institute) Prometheus created life from clay, and within many biologists and surgeons there is a primal desire to do the same from the materials at hand, in an effort to stave off death and disease. Organ transplantation has been one Promethean solution, but a lack of donor organs, ethical and other issues limits the stretch of this technology Read more from the original source: Prometheus and I: building new body parts from stem cells (15 Nov 2011) - Video … Continue reading →

Major General James Gilman, Commanding General of the US Army Medical Research and Material Command, outlined the US army's extensive research efforts in stem cell technologies and their mission to discover, develop and translate regenerative medicine. He spoke about the military's desire to partner with academia and industry to generate effective treatments for volume, bone, muscle and tissue injuries and about spinal cord regeneration as the military's biggest challenge and hope. The rest is here: 2011 Summit: Harnessing Regenerative Medicine for US Service-members, Major General James K. Gilman - Video … Continue reading →

Robert Klein, former chair of the California Institute of Regenerative Medicine (CIRM), presented this year's advocacy keynote, addressing the looming black cloud over funding for stem cell research in the US. Klein explained that in a financial downturn, creating long term, big picture investments for donors is absolutely necessary to bring to new treatment modalities to market. Visit link: 2011 Summit: Government … Continue reading →

Andy Grove, PhD and Former CEO of Intel Corporation, dared to suggest that translational medicine will be a "bridge to nowhere" if the way we handle the development of new drugs does not undergo a serious transformation. He proposed a radical rethinking of our whole regulatory and IP system, encouraging all members of the stem cell community to stimulate action and push for change. Grove asked attendees to consider how stem cell science will live in the current system and to pioneer innovative ways to get therapies to the clinic faster. Read the original: 2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD - Video … Continue reading →

2/24/2010-Osiris Therapeutics (NASDAQ:OSIR) said Wednesday according to its most recent study of 52 heart-attack patients, its stem cell therapy Prochymal improved cardiac function and reduced irregular heartbeats compared to a control group. Additionally, a larger Phase II study is underway on patients who have had severe heart attacks Visit link: Osiris (NASDAQ:OSIR) Reports Positive Study Results for Prochymal - Video … Continue reading →